首页|普拉洛芬滴眼液联合妥布霉素地塞米松滴眼液治疗白内障术后患者的效果

普拉洛芬滴眼液联合妥布霉素地塞米松滴眼液治疗白内障术后患者的效果

扫码查看
目的:观察普拉洛芬滴眼液联合妥布霉素地塞米松滴眼液治疗白内障术后患者的效果.方法:回顾性分析 2021 年 6 月至2023 年 5 月该院收治的 84 例白内障术后患者的临床资料,按治疗方案不同将其分为对照组与研究组各 42 例.对照组采用妥布霉素地塞米松滴眼液治疗,研究组在对照组基础上联合普拉洛芬滴眼液治疗.比较两组眼部康复指标(干眼症状、前房闪辉值、眼压)水平、泪腺泪膜指标[泪液分泌试验(SIT)、泪膜破裂时间(BUT)、角膜荧光素染色评分(FL)]水平、泪液炎性因子[超敏C反应蛋白(hs-CRP)、白细胞介素-6(IL-6)、肿瘤坏死因子-α(TNF-α)]水平,以及术后并发症发生率.结果:治疗后,两组干眼症状评分、前房闪辉值、眼压水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组SIT、BUT水平均高于治疗前,且研究组高于对照组,两组FL评分均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组hs-CRP、IL-6、TNF-α水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);研究组并发症发生率为4.76%,低于对照组的19.05%,差异有统计学意义(P<0.05).结论:普拉洛芬滴眼液联合妥布霉素地塞米松滴眼液治疗白内障术后患者可改善泪腺泪膜指标水平,降低眼部康复指标水平、泪液炎性因子水平和并发症发生率,其效果优于单纯妥布霉素地塞米松滴眼液治疗.
Effects of Pranoprofen eye drops combined with Tobramycin dexamethasone eye drops in treatment of patients after cataract surgery
Objective:To observe effects of Pranoprofen eye drops combined with Tobramycin dexamethasone eye drops in treatment of patients after cataract surgery.Methods:The clinical data of 84 patients with cataract surgery admitted to this hospital from June 2021 to May 2023 were retrospectively analyzed.They were divided into control group and study group according to different treatment options,42 cases in each.The control group was treated with Tobramycin dexamethasone eye drops,while the study group was treated with Pranoprofen eye drops on the basis of that of the control group.The levels of ocular rehabilitation indexes(dry eye symptoms,anterior chamber flare value,intraocular pressure),the lacrimal gland and tear film indexes[the Schirmer test(SIT),tear film break-up time(BUT),corneal fluorescein staining score(FL)]and tear inflammatory factors[high-sensitivity C-reactive protein(hs-CRP),interleukin-6(IL-6),tumor necrosis factor-α(TNF-α)],and the incidence of postoperative complications were compared between the two groups.Results:After the treatment,the scores of dry eye symptoms,anterior chamber flash value and intraocular pressure in the two groups were lower than those before the treatment,those in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).The levels of SIT and BUT in the two groups were higher than those before the treatment,and those in the study group were higher than those in the control group;the FL scores of the two groups were lower than those before the treatment,and that in the study group was lower than that in the control group;and the differences were statistically significant(P<0.05).The levels of hs-CRP,IL-6 and TNF-α in the two groups were lower than those before the treatment,those in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).Further,the incidence of complications in the study group was 4.76%,which was lower than 19.05%in the control group,the difference was statistically significant(P<0.05).Conclusions:Pranoprofen eye drops combined with Tobramycin dexamethasone eye drops in the treatment of the patients after cataract surgery can improve the levels of lacrimal gland and tear film indexes and reduce the levels of eye rehabilitation indexes,the levels of tear inflammatory factors and the incidence of complications.Moreover,it is superior to single Tobramycin dexamethasone eye drops treatment.

Tobramycin dexamethasone eye dropsPranoprofen eye dropsCataractInflammatory factorComplication

贾趁霞

展开 >

长垣市人民医院眼科,河南 新乡 453400

妥布霉素地塞米松滴眼液 普拉洛芬滴眼液 白内障 炎性因子 并发症

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(9)
  • 14